/Investor DB

Karista — 2026 Investments

1 investments dated 2026 · listed companies and verified rows first · show all

Waivwaiv.comMar 2026 · $33M

Waiv provides AI-powered digital pathology services for biopharma companies, offering co-development partnerships that span AI biomarker discovery, algorithm validation, SaMD development, regulatory strategy (CE-IVD/FDA), and companion diagnostic commercialization.

AI & Machine LearningBiotechDigital Health

Co-investorsSerenaSistaAlpha Intelligence CapitalOTB VenturesSerena Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.